Rxivist logo

Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer.

By Lucy Ireland, Almudena Santos, Fiona Campbell, Carlos Figueiredo, Lesley Ellies, Ulrike Weyer-Czernilofsky, Thomas Bogenrieder, Michael Schmid, Ainhoa Mielgo

Posted 23 Jul 2017
bioRxiv DOI: 10.1101/165068 (published DOI: 10.1038/s41388-017-0115-x)

Breast cancer remains the leading cause of cancer death in women due to metastasis and the development of resistance to established therapies. Macrophages are the most abundant immune cells in the breast tumor microenvironment and can both inhibit and support cancer progression. Thus, gaining a better understanding of how macrophages support cancer could lead to the development of more effective therapies. In this study, we find that breast cancer associated macrophages express high levels of insulin-like growth factors 1 and 2 (IGFs) and are the main source of IGFs within both primary and metastatic tumours. 75% of breast cancer patients show activation of Insulin/IGF-1 receptor signaling and this correlates with increased macrophage infiltration and advanced tumor stage. In patients with invasive breast cancer, activation of Insulin/IGF-1 receptors increased to 87%. Blocking IGF in combination with paclitaxel, a chemotherapeutic agent commonly used to treat breast cancer, showed a significant reduction in tumor cell proliferation and lung metastasis in a pre-clinical breast cancer model compared to paclitaxel monotherapy. Our findings provide the rationale for further developing the combination of paclitaxel with IGF blockers for the treatment of invasive breast cancer, and Insulin/IGF1R activation and IGF+ stroma cells as potential biomarker candidates for further evaluation.

Download data

  • Downloaded 309 times
  • Download rankings, all-time:
    • Site-wide: 136,551
    • In cancer biology: 3,754
  • Year to date:
    • Site-wide: 188,845
  • Since beginning of last month:
    • Site-wide: 190,796

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide